A kind of rvg-cd70 CAR-T cell and its preparation method and application

A technology of RVG-CD70CAR-T cells, which is applied in the fields of molecular biology and cell biology, can solve problems such as the difficulty of large-scale complete resection in surgery, and achieve the effect of increasing T cell killing specificity and efficient tumor killing activity

Active Publication Date: 2021-04-27
NANJING NORMAL UNIVERSITY
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Brain tumors include primary brain tumors and brain metastases. The best treatment method is complete surgical resection. However, due to the unresectable nature of normal brain tissue and the characteristics of extensive invasive growth of malignant tumors into the brain, large-scale complete surgical resection is recommended. extremely difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of rvg-cd70 CAR-T cell and its preparation method and application
  • A kind of rvg-cd70 CAR-T cell and its preparation method and application
  • A kind of rvg-cd70 CAR-T cell and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1: Preparation of lentiviral expression vector

[0052] Gene synthesis RVG-SCFV(anti CD70)-CD8 TM - 4-1BB-CD3ζ fusion gene sequence, the gene sequence is shown in SEQID NO.8, which is connected to the PLV vector through enzyme digestion transformation, and the upstream of the gene is the EF-1α promoter. Transform the DH5α Escherichia coli strain with the vector, screen with ampicillin, obtain positive clones, extract the plasmid, identify the clones by enzyme digestion, and obtain PLV-RVG-SCFV(anti CD70)-CD8 TM -4-1BB-CD3ζ lentiviral packaging vector, see figure 1 .

Embodiment 2

[0053] Example 2: Preparation of lentivirus

[0054] 24 hours before transfection, use about 8×10 per bottle 6 293T cells were inoculated into T75 culture flasks. Make sure that the cells are about 80% confluent and evenly distributed in the culture flask for lentiviral packaging.

[0055] Prepare Plasmid and Transfection Reagent Dilutions

[0056] 1. Vortex to mix the PEI transfection reagent.

[0057] 2. Prepare 2 centrifuge tubes, and prepare plasmid and transfection reagent dilutions in the following order.

[0058]

[0059]

[0060] 3. Mix well.

[0061] 4. Add the transfection reagent dilution (centrifuge tube 2) into the plasmid DNA solution (centrifuge tube 1), and mix thoroughly immediately. Note that the join order is very important.

[0062] 5. Incubate the transfection mixture at room temperature for 15-20 minutes.

[0063] 6. Add 1ml of the transfection mixture into the well-prepared 293T cell culture flask, and gently blow and aspirate the medium to ...

Embodiment 3

[0067] Example 3: Preparation of RVG-CD70 CAR-T cells

[0068] Take 0.5ml of blood for rapid detection of pathogenic microorganisms to rule out microbial infections such as HBV, HCV, HDV, HEV, HIV-1 / 2, Treponema pallidum and parasites. Peripheral blood mononuclear cells (PBMC) were collected from the patients by an apheresis machine. Configure complete growth medium, add 5% autologous AB or FBS to PBS, IL-2 concentration is 20ng / ml, and dilute the isolated PBMC with medium to 2×10 6 / ml, take 50u1 flow cytometry to detect the purity of T cells in PBMC. On day 0, configure buffer1, add 1% FBS to PBS, shake the beads for 30s or manually shake them up and down for 5 minutes, take out the CD3 / CD8 beads according to the ratio of beads to T cells 3 to 1, put them in a 1.5ml EP tube, add 1ml Wash the beads with Buffer1, then use a magnet to suck the beads from the EP tube for 1 min, discard the washing solution, repeat twice, then use the medium to resuspend the beads to the origin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of molecular biology and cell biology, and in particular relates to a CAR-T cell capable of passing through the blood-brain barrier and specifically recognizing CD70 and a preparation method thereof, wherein RVG-SCFV (Anti CD70)-CD8 TM The ‑4‑1BB‑CD3ζ molecule is expressed in T cells. The present invention uses the CD70 antibody for the construction of CAR-T cells, and proposes to use the CD70 molecule as the target antigen. When the constructed CAR-T cells contact the tumor cells expressing the CD70 molecule, the distance will be pulled the closest, increasing the killing of T cells. Specificity; the prepared RVG‑CD70 CAR‑T cells possess the RVG protein that helps cross the blood-brain barrier, can be more efficiently localized in the brain and exert tumor killing activity, and can be used for the preparation of brain tumors with high expression of CD70 molecules CAR‑T cell drugs.

Description

technical field [0001] The present invention belongs to the fields of molecular biology and cell biology, and specifically relates to a CAR-T cell targeting the brain with RVG protein and specifically recognizing CD70 and a preparation method thereof, and its use in treating brain tumors related to highly expressed CD70 molecules application in medicine. Background technique [0002] The hypofunction of the immune system of cancer patients due to radiotherapy and chemotherapy is an important reason for the recurrence of the disease, and it is also a major problem that plagues the medical field. Chimeric antigen receptor T-cell immunotherapy (CAR-T), with its unique anti-tumor advantages, has become a hot spot in global biotechnology competition. CAR-T cells combine the single-chain variable region (SCFV) of an antibody that can recognize a certain tumor antigen with CD8 TM , 4-1BB, CD3-ζ chain and other intracellular regions are coupled into a chimeric protein, which is tr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C07K19/00C12N15/867A61K39/00A61P35/00
CPCA61K2039/5156A61P35/00A61K39/001102A61K2039/80C07K14/7051C07K14/70517C07K14/70578C07K16/2875C07K2317/622C07K2319/03C07K2319/33C07K2319/74C12N5/0636C12N15/86C12N2510/00C12N2740/15043C12N2800/107
Inventor 纪锋郭志刚孙裕铃张凡景丽李恩洁马颖胡志刚
Owner NANJING NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap